R. Prenzel

431 total citations
13 papers, 303 citations indexed

About

R. Prenzel is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, R. Prenzel has authored 13 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in R. Prenzel's work include Lung Cancer Treatments and Mutations (5 papers), Cancer survivorship and care (2 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers). R. Prenzel is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Cancer survivorship and care (2 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers). R. Prenzel collaborates with scholars based in Germany, United Kingdom and Estonia. R. Prenzel's co-authors include Richard Schulz, A Blau, Jan Börgel, J. Schmitt, Ingo Fietze, Stefan Andreas, H.-W. Duchna, S. Tasci, Steffen T. Simon and Claudia Bausewein and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Respiratory Journal.

In The Last Decade

R. Prenzel

13 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Prenzel Germany 4 165 160 94 75 48 13 303
Caroline Chao Australia 7 246 1.5× 85 0.5× 13 0.1× 17 0.2× 64 1.3× 14 367
Anda Hazenberg Netherlands 8 302 1.8× 62 0.4× 47 0.5× 21 0.3× 10 0.2× 22 365
Teresa Gómez García Spain 9 121 0.7× 111 0.7× 31 0.3× 20 0.3× 14 0.3× 39 303
Marinella Rabner Israel 7 276 1.7× 168 1.1× 35 0.4× 14 0.2× 6 0.1× 8 419
Adriana Aguilar Argentina 8 356 2.2× 29 0.2× 179 1.9× 34 0.5× 144 3.0× 12 449
Jorge Brieva Australia 10 138 0.8× 143 0.9× 7 0.1× 90 1.2× 16 0.3× 14 327
Aafke F. Meinesz Netherlands 10 227 1.4× 201 1.3× 120 1.3× 12 0.2× 5 0.1× 17 374
Florin Mihălţan Romania 8 99 0.6× 123 0.8× 27 0.3× 26 0.3× 9 0.2× 69 245
Georges Halabi Switzerland 10 44 0.3× 76 0.5× 34 0.4× 24 0.3× 21 0.4× 22 348
James R. Mullen United States 5 264 1.6× 243 1.5× 20 0.2× 49 0.7× 17 0.4× 7 414

Countries citing papers authored by R. Prenzel

Since Specialization
Citations

This map shows the geographic impact of R. Prenzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Prenzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Prenzel more than expected).

Fields of papers citing papers by R. Prenzel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Prenzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Prenzel. The network helps show where R. Prenzel may publish in the future.

Co-authorship network of co-authors of R. Prenzel

This figure shows the co-authorship network connecting the top 25 collaborators of R. Prenzel. A scholar is included among the top collaborators of R. Prenzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Prenzel. R. Prenzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Prenzel, R., Kay Willborn, Cora Hallas, et al.. (2017). MA04.05 P53 Non-Disruptive Mutation is a Negative Predictive Factor for OS and PFS in EGFR M+ NSCLC Treated with TKI. Journal of Thoracic Oncology. 12(1). S359–S360. 2 indexed citations
2.
3.
Griesinger, Frank, R. Prenzel, Cora Hallas, et al.. (2016). P53 non-disruptive mutation is a negative predictive factor in EGFR M+ NSCLC treated with TKI. Annals of Oncology. 27. vi426–vi426. 3 indexed citations
4.
Griesinger, Frank, Martin Falk, Andreas Kluge, et al.. (2016). Intercalated TKI and chemotherapy induction in EGFR mt+ NSCLC stage IIIA and IIIB: report of 3 cases with complete pathologic remission in mediastinal lymph nodes. Pneumologie. 70(S 01). 1 indexed citations
5.
Prenzel, R., et al.. (2015). 3119 P53 disruptive mutation is a negative predictive factor in EGFR M+ NSCLC treated with TKI. European Journal of Cancer. 51. S643–S643. 1 indexed citations
6.
Weingärtner, Vera, Michael Schwarz-Eywill, R. Prenzel, et al.. (2015). Characteristics of episodic breathlessness as reported by patients with advanced chronic obstructive pulmonary disease and lung cancer: Results of a descriptive cohort study. Palliative Medicine. 29(5). 420–428. 32 indexed citations
7.
Schwarz-Eywill, Michael, R. Prenzel, Claudia Bausewein, et al.. (2014). Breathlessness, Functional Status, Distress, and Palliative Care Needs Over Time in Patients With Advanced Chronic Obstructive Pulmonary Disease or Lung Cancer: A Cohort Study. Journal of Pain and Symptom Management. 48(4). 569–581.e1. 88 indexed citations
8.
Prenzel, R., Kay Willborn, Markus Falk, et al.. (2014). Incidence of EGFR, kras, BRAF, ALK, and p53 alterations in a cohort of 218 consecutively tested patients from a certified lung cancer center: Correlation with clinical characteristics and treatment outcome.. Journal of Clinical Oncology. 32(15_suppl). e19064–e19064. 2 indexed citations
9.
Ramsenthaler, Christina, Claudia Bausewein, Christian von Scheve, et al.. (2012). Typische Krisen und Bedürfnisse von Patienten mit COPD oder Lungenkrebs im letzten Lebensjahr - eine Literaturübersicht. Zeitschrift für Palliativmedizin. 13(3). 134–141. 2 indexed citations
10.
Prenzel, R., et al.. (2008). Medikamenten-induzierte Alveolitis unterInfliximab-/Azathioprin-Therapie. Pneumologie. 62(4). 204–208. 11 indexed citations
11.
Schulz, Richard, A Blau, Jan Börgel, et al.. (2007). Sleep apnoea in heart failure. European Respiratory Journal. 29(6). 1201–1205. 156 indexed citations
12.
13.
Jansen, W, et al.. (1991). Slow Release Isosorbide-5-Mononitrate Therapy in Angina Pectoris. Cardiology. 79(2). 78–85. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caroline Chao Breakdown of academic impact, for papers by Anda Hazenberg Breakdown of academic impact, for papers by Teresa Gómez García Breakdown of academic impact, for papers by Marinella Rabner Breakdown of academic impact, for papers by Adriana Aguilar Breakdown of academic impact, for papers by Jorge Brieva Breakdown of academic impact, for papers by Aafke F. Meinesz Breakdown of academic impact, for papers by Florin Mihălţan Breakdown of academic impact, for papers by Georges Halabi Breakdown of academic impact, for papers by James R. Mullen
Rankless by CCL
2026